Page 85 - GTM-2-2

Global Translational Medicine Nanoparticles in cancer treatment

Encapsuled nanoparticles “re-educate” tumor-associated 47. Nag OK, Delehanty JB, 2019, Active cellular and subcellular
macrophages and exhibit anti-tumor effects on breast cancer targeting of nanoparticles for drug delivery. Pharmaceutics,
following STAT3 suppression. PLoS One, 8: e65896. 11: 543.
https://doi.org/10.1371/journal.pone.0065896 https://doi.org/10.3390/pharmaceutics11100543
41. Byrne JD, Betancourt T, Brannon-Peppas L, 2008, Active 48. Torchilin VP, 2005, Recent advances with liposomes as
targeting schemes for nanoparticle systems in cancer pharmaceutical carriers. Nat Rev Drug Discov, 4: 145–160.
therapeutics. Adv Drug Deliv Rev, 60: 1615–1626. https://doi.org/10.1038/nrd1632
https://doi.org/10.1016/j.addr.2008.08.005 49. Carita AC, Eloy JO, Chorilli M, et al., 2018, Recent advances
42. Alexis F, Pridgen E, Molnar LK, et al., 2008, Factors and perspectives in liposomes for cutaneous drug delivery.
affecting the clearance and biodistribution of polymeric Curr Med Chem, 25: 606–635.
nanoparticles. Mol Pharm, 5: 505–515. https://doi.org/10.2174/0929867324666171009120154
https://doi.org/10.1021/mp800051m 50. Sykes EA, Chen J, Zheng G, et al., 2014, Investigating the
43. Sarvari P, Sarvari P, Ramírez-Díaz I, et al., 2022, Advances impact of nanoparticle size on active and passive tumor
of epigenetic biomarkers and epigenome editing for early targeting efficiency. ACS Nano, 8: 5696–5706.
diagnosis in breast cancer. Int J Mol Sci, 23: 9521. https://doi.org/10.1021/nn500299p
https://doi.org/10.3390/ijms23179521 51. Carmeliet P, Jain RK, 2000, Angiogenesis in cancer and
44. Shi J, Xiao Z, Kamaly N, et al., 2011, Self-assembled targeted other diseases. Nature, 407: 249–257.
nanoparticles: Evolution of technologies and bench to https://doi.org/10.1038/35025220
bedside translation. Acc Chem Res, 44: 1123–1134.
52. Matsumura Y, Maeda H, 1986, A new concept for
https://doi.org/10.1021/ar200054n macromolecular therapeutics in cancer chemotherapy:
45. Danhier F, Feron O, Préat V, 2010, To exploit the tumor Mechanism of tumoritropic accumulation of proteins and
microenvironment: Passive and active tumor targeting of the antitumor agent smancs. Cancer Res, 46: 6387–6392.
nanocarriers for anti-cancer drug delivery. J Control Release, 53. Padera TP, Stoll BR, Tooredman JB, et al., 2004, Cancer cells
148: 135–146. compress intratumour vessels. Nature, 427: 695–695.
https://doi.org/10.1016/j.jconrel.2010.08.027 https://doi.org/10.1038/427695a
46. Bae YH, Park K, 2011, Targeted drug delivery to tumors: 54. Jain RK, 1994, Barriers to drug delivery in solid tumors. Sci
Myths, reality and possibility. J Control Release, 153: 198. Am, 271: 58–65.
https://doi.org/10.1016/j.jconrel.2011.06.001 https://doi.org/10.1038/scientificamerican0794-58

Volume 2 Issue 2 (2023) 6 https://doi.org/10.36922/gtm.0394